Janus Henderson Group PLC Karyopharm Therapeutics Inc. Transaction History

Janus Henderson Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.79 - $4.59 $109 - $279	-61 Reduced 0.16%	38,053 $68,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $73,612 - $101,606	25,920 Added 212.56%	38,114 $148,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $2 - $5	-1 Reduced 0.01%	12,194 $41,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $102 - $145	-25 Reduced 0.2%	12,195 $66,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $236 - $477	57 Added 0.47%	12,220 $55,000
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $5 - $14	1 Added 0.01%	12,163 $90,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $63,364 - $104,714	12,162 New	12,162 $78,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $54 Million - $82.1 Million	-3,252,828 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $46.8 Million - $90.2 Million	3,252,828 New	3,252,828 $62.5 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.